Guanhao Biotech Co.,Ltd. (SHE:300238)
China flag China · Delayed Price · Currency is CNY
17.17
+0.48 (2.88%)
Jan 23, 2026, 3:04 PM CST

Guanhao Biotech Company Description

Guanhao Biotech Co.,Ltd. develops, manufactures, and sells regenerative medicines and life sciences products primarily in China.

It offers NormalGEN, a dura repair patch; GrandNeuro, a dura repair patch; ThormalGEN, a surgical patch; DermalGEN, a wound dressing product; IREAL breast patch; and Youvision corneal graft, as well as license in intraocular lenses.

The company also provides Biological dura, a spinal patch; Type B dura, a spinal patch; Sterile Bio Wound Membrane; Ario Mesh; Thoracic Surgery Repair Diaphragm; and Cympic Benvimod Cream for psoriasis.

In addition, it offers artificial lens and medical instruments; and cell technology services. Its products can be used in neurosurgery, thoracic general surgery, ophthalmology, dermatology, orthopedics, cosmetology, plastic surgery, and other areas.

Guanhao Biotech Co.,Ltd. was founded in 1999 and is headquartered in Guangzhou, China.

Guanhao Biotech Co.,Ltd.
CountryChina
Founded1999
IndustryBiotechnology
SectorHealthcare
Employees530
CEOFeng Zhao

Contact Details

Address:
No. 12 Yuyan Road
Guangzhou, 510530
China
Phone86 20 3205 2806
Websiteguanhaobio.com

Stock Details

Ticker Symbol300238
ExchangeShenzhen Stock Exchange
Fiscal YearJanuary - December
Reporting CurrencyCNY
ISIN NumberCNE100001575
SIC Code3842

Key Executives

NamePosition
Feng ZhaoGeneral Manager
Ruofeng YiChief Financial Officer and Accounting Supervisor
Junhui Zhao CPAExecutive Vice President
Xu QingrongDeputy GM and Secretary
Zhen YouDeputy General Manager
Weikun ZhangDeputy General Manager
Huaixin HouDeputy General Manager
Xianggui LinDeputy General Manager
Prof. Guofeng XuChief Technology Officer